# clinical trials

5 articles.

- [Why BPC-157 Isn't FDA Approved Yet](https://moleculenotes.com/regulatory-and-approval-status/why-is-bpc-157-not-approved-by-fda.md): Why is BPC-157 not approved by FDA despite 150 studies. Discover regulatory, funding, and trial barriers that have stalled this compound for decades.
- [GHK-Cu Peptide: What the Science Actually Shows](https://moleculenotes.com/clinical-evidence-and-mechanisms/ghk-cu-clinical-trial-evidence-review.md): Discover what GHK-Cu clinical trial evidence actually reveals. Our comprehensive review separates hype from science. Read the facts now.
- [Retatrutide HbA1c Reduction Diabetes Study](https://moleculenotes.com/clinical-trials-and-research/retatrutide-hba1c-reduction-diabetes-study.md): Explore how retatrutide's impressive HbA1c reduction and weight loss potential can help manage type 2 diabetes effectively. Read the latest study insights now.
- [TRIUMPH Trial Retatrutide Phase 3 Obesity Study](https://moleculenotes.com/clinical-trials-and-research/triumph-trial-retatrutide-phase-3-obesity.md): Discover the triumph trial for retatrutide phase 3 and its impact on obesity treatment. Learn how this study could influence FDA approval. Read more today.
- [Retatrutide NEJM 2023 Phase 2 Obesity Results](https://moleculenotes.com/clinical-trials-and-research/retatrutide-nejm-2023-phase-2-obesity.md): Explore the retatrutide NEJM 2023 phase 2 obesity trial results showing 24.2% weight loss. Read more to understand its potential in obesity treatment.